Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-5f56664f6-spj7j Total loading time: 0 Render date: 2025-05-08T03:05:46.131Z Has data issue: false hasContentIssue false

6 - Common risk factors and prevention

from Section II - Clinical epidemiology and risk factors

Published online by Cambridge University Press:  05 May 2010

By
Michael Brainin ,
Yvonne Teuschl  and
Karl Matz
Edited by
Michael Brainin  and
Wolf-Dieter Heiss
Michael Brainin
Affiliation:
Zentrum für Klinische Neurowissenschaften, Donnau-Universität, Krems, Austria
Wolf-Dieter Heiss
Affiliation:
Universität zu Köln
Get access

Summary

The aim of primary prevention is to reduce the risk of first-ever stroke in asymptomatic people. Seven factors are regarded as potentially modifiable risk factors for vascular diseases: high blood pressure, high cholesterol, smoking, excessive or heavy regular alcohol consumption, physical inactivity, overweight and dietary factors. The strategy in primary prevention is to lower stroke risk attributed to these factors through education, lifestyle changes and medication. Non-modifiable risk factors arising from diseases such as atrial fibrillation or diabetes mellitus can be lowered by controlling and treating the underlying disorder. Targets of primary stroke prevention can be the entire population or high-risk – but stroke-free – individuals partly suffering from disorders such as hypertension or diabetes mellitus.

Lifestyle factors

Stroke prevalence has been associated with individual lifestyle factors (e.g. smoking, exercise, body mass index (BMI), alcohol consumption) in several studies. Healthy lifestyle in general was considered in one large prospective cohort study of healthy women. In this study, healthy lifestyle, consisting of abstinence from smoking, low-normal body mass index, moderate alcohol consumption, regular exercise and healthy diet, was found to be associated with a reduction in ischemic stroke (RR 0.3; 95% CI 0.1–0.6) [1]. Using the data of two large cohort studies, the Nurses' Health Study (71 243 women) and the Health Professionals Follow-up Study (43 685 men), Chiuve et al. [2] defined a low-risk lifestyle score based on the five lifestyle components non-smoking, moderate activity ≥ 30 min/day, healthy diet, body mass index < 25 kg/m2 and modest alcohol consumption (men 5–30 g/day, women 5–15 g/day).

Type
Chapter
Information
Textbook of Stroke Medicine , pp. 89 - 104
Publisher: Cambridge University Press
Print publication year: 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Kurth, T, Moore, S, Gaziano, J, Kase, C, Stampfer, M, Berger, K, Buring, J. Healthy lifestyle and the risk of stroke in women. Arch Intern Med 2006; 166:1403–9.CrossRefGoogle ScholarPubMed
Chiuve, SE, Rexrode, KM, Spiegelman, D, Logroscino, G, Manson, JE, Rimm, EB. Primary prevention of stroke by healthy lifestyle. Circulation 2008; 118:947–54.CrossRefGoogle ScholarPubMed
Mathers, CD, Loncar, D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3:e442.CrossRefGoogle ScholarPubMed
Wolf, PA, D'Agostino, RB, Kannel, WB, Bonita, R, Belanger, AJ. Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA 1988; 259:1025–9.CrossRefGoogle ScholarPubMed
Kawachi, I, Colditz, GA, Stampfer, MJ, Willett, WC, Manson, JE, Rosner, B, et al. Smoking cessation in relation to total mortality rates in women. A prospective cohort study. Ann Intern Med 1993; 119:992–1000.CrossRefGoogle ScholarPubMed
Wannamethee, SG, Shaper, AG, Whincup, PH, Walker, M. Smoking cessation and the risk of stroke in middle-aged men. JAMA 1995; 274:155–60.CrossRefGoogle ScholarPubMed
Iso, H, Date, C, Yamamoto, A, Toyoshima, H, Watanabe, Y, Kikuchi, S, et al. JACC Study Group. Smoking cessation and mortality from cardiovascular disease among Japanese men and women: the JACC Study. Am J Epidemiol 2005; 161:170–9.CrossRefGoogle Scholar
Shinton, R, Beevers, G. Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989; 298:789–94.CrossRefGoogle ScholarPubMed
Teunissen, LL, Rinkel, GJ, Algra, A, Gijn, J. Risk factors for subarachnoid hemorrhage: a systematic review. Stroke 1996; 27:544–9.CrossRefGoogle ScholarPubMed
Broderick, JP, Viscoli, CM, Brott, T, Kernan, WN, Brass, LM, Feldmann, E, et al. Hemorrhagic Stroke Project Investigators. Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable. Stroke 2003; 34:1375–81.CrossRefGoogle Scholar
Anderson, CS, Feigin, V, Bennett, D, Lin, RB, Hankey, G, Jamrozik, K. Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS) Group. Active and passive smoking and the risk of subarachnoid hemorrhage: an international population-based case-control study. Stroke 2004; 35:633–7.CrossRefGoogle ScholarPubMed
Ariesen, MJ, Claus, SP, Rinkel, GJ, Algra, A. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke 2003; 34:2060–5.CrossRefGoogle ScholarPubMed
Kurth, T, Kase, CS, Berger, K, Schaeffner, ES, Buring, JE, Gaziano, JM. Smoking and the risk of hemorrhagic stroke in men. Stroke 2003; 34:1151–5.CrossRefGoogle ScholarPubMed
Kurth, T, Kase, CS, Berger, K, Gaziano, JM, Cook, NR, Buring, JE. Smoking and risk of hemorrhagic stroke in women. Stroke 2003; 34:2792–5.CrossRefGoogle ScholarPubMed
Howard, G, Wagenknecht, , Burke, GL, Diez-Roux, A, Evans, GW, McGovern, P, et al. Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. JAMA 1998; 279:119–24.CrossRefGoogle ScholarPubMed
Lee, PN, Forey, BA. Environmental tobacco smoke exposure and risk of stroke in nonsmokers: a review with meta-analysis. J Stroke Cerebrovasc Dis 2006; 15:190–201.CrossRefGoogle ScholarPubMed
Håheim, LL, Holme, I, Hjermann, I, Leren, P. Smoking habits and risk of fatal stroke: 18 years follow up of the Oslo Study. J Epidemiol Community Health 1996; 50:621–4.CrossRefGoogle ScholarPubMed
,WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Ischemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. Lancet 1996; 348:498–505.
,WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study. Lancet 1996; 348:505–10.
Stead, LF, Perera, R, Bullen, C, Mant, D, Lancaster, T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008; CD000146.
Hughes, JR, Stead, LF, Lancaster, T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2007; CD000031.
Cahill, K, Stead, LF, Lancaster, T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2007; CD006103.
Cahill, K, Ussher, M. Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation. Cochrane Database Syst Rev 2007; CD005353.
Barth, J, Critchley, J, Bengel, J. Psychosocial interventions for smoking cessation in patients with coronary heart disease. Cochrane Database Syst Rev 2008; CD006886.
Mazzaglia, G, Britton, AR, Altmann, DR, Chenet, L. Exploring the relationship between alcohol consumption and non-fatal or fatal stroke: a systematic review. Addiction 2001; 96:1743–56.CrossRefGoogle ScholarPubMed
Reynolds, K, Lewis, B, Nolen, JD, Kinney, GL, Sathya, B, He, J. Alcohol consumption and risk of stroke: a meta-analysis. JAMA 2003; 289:579–88.CrossRefGoogle ScholarPubMed
Rimm, EB, Williams, P, Fosher, K, Criqui, M, Stampfer, MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 1999; 319:1523–8.CrossRefGoogle ScholarPubMed
Lange, DW, Hijmering, ML, Lorsheyd, A, Scholman, WL, Kraaijenhagen, RJ, Akkerman, JW, et al. Rapid intake of alcohol (binge drinking) inhibits platelet adhesion to fibrinogen under flow. Alcohol Clin Exp Res 2004; 28:1562–8.CrossRefGoogle ScholarPubMed
Truelsen, T, Gronbaek, M, Schnohr, P, Boysen, G. Intake of beer, wine, and spirits and risk of stroke: the Copenhagen city heart study. Stroke 1998; 29:2467–72.CrossRefGoogle ScholarPubMed
Malarcher, AM, Giles, WH, Croft, JB, Wozniak, MA, Wityk, RJ, Stolley, PD, et al. Alcohol intake, type of beverage, and the risk of cerebral infarction in young women. Stroke 2001; 32:77–83.CrossRefGoogle ScholarPubMed
Mukamal, K, Ascherio, A, Mittleman, M, Conigrave, K, Camargo, C, Kawachi, I, et al. Alcohol and risk for ischemic stroke in men: the role of drinking patterns and usual beverage. Ann Intern Med 2005; 142:11–19.CrossRefGoogle ScholarPubMed
Hillbom, M, Numminen, H, Juvela, S. Recent heavy drinking of alcohol and embolic stroke. Stroke 1999; 30:2307–12.CrossRefGoogle ScholarPubMed
Wannamethee, SG, Shaper, AG. Patterns of alcohol intake and risk of stroke in middle-aged British men. Stroke 1996: 1033–9.CrossRefGoogle ScholarPubMed
Kiyohara, Y, Kato, I, Iwamoto, H, Nakayama, K, Fujishima, M. The impact of alcohol and hypertension on stroke incidence in a general Japanese population. The Hisayama Study. Stroke 1995; 26:368–72.CrossRefGoogle Scholar
Bazzano, , Gu, D, Reynolds, K, Wu, X, Chen, CS, Duan, X, et al. Alcohol consumption and risk for stroke among Chinese men. Ann Neurol 2007; 62:569–78.CrossRefGoogle ScholarPubMed
Dickinson, HO, Mason, JM, Nicolson, DJ, Campbell, F, Beyer, FR, Cook, JV, et al. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens 2006; 24:215–33.CrossRefGoogle ScholarPubMed
Djoussé, L, Levy, D, Benjamin, EJ, Blease, SJ, Russ, A, Larson, MG, et al. Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. Am J Cardiol 2004; 93:710–3.CrossRefGoogle ScholarPubMed
Kurth, T, Gaziano, J, Berger, K, Kase, C, Rexrode, K, Cook, N, et al. Body mass index and the risk of stroke in men. Arch Intern Med 2002; 162:2557–62.CrossRefGoogle ScholarPubMed
Jood, K, Jern, C, Wilhelmsen, L, Rosengren, A. Body mass index in mid-life is associated with a first stroke in men: a prospective population study over 28 years. Stroke 2004; 35:2764–9.CrossRefGoogle ScholarPubMed
Kurth, T, Gaziano, J, Rexrode, K, Kase, C, Cook, N, Manson, J, et al. Prospective study of body mass index and risk of stroke in apparently healthy women. Circulation 2005; 111:1992–8.CrossRefGoogle ScholarPubMed
Hu, G, Tuomilehto, J, Silventoinen, K, Sarti, C, Mannisto, S, Jousilahti, P. Body mass index, waist circumference, and waist-hip ratio on the risk of total and type-specific stroke. Arch Intern Med 2007; 167:1420–7.CrossRefGoogle ScholarPubMed
Abbott, RD, Behrens, GR, Sharp, DS, Rodriguez, BL, Burchfiel, CM, Ross, GW, et al. Body mass index and thromboembolic stroke in nonsmoking men in older middle age. The Honolulu Heart Program. Stroke 1994; 25:2370–6.CrossRefGoogle ScholarPubMed
Rexrode, KM, Hennekens, CH, Willett, WC, Colditz, GA, Stampfer, MJ, Rich-Edwards, JW, et al. A prospective study of body mass index, weight change, and risk of stroke in women. JAMA 1997; 277:1539–45.CrossRefGoogle ScholarPubMed
Song, YM, Sung, J, Davey Smith, G, Ebrahim, S. Body mass index and ischemic and hemorrhagic stroke: a prospective study in Korean men. Stroke 2004; 35:831–6.CrossRefGoogle ScholarPubMed
Park, JW, Lee, SY, Kim, SY, Choe, H, Jee, SH. BMI and stroke risk in Korean women. Obesity 2008; 16:396–401.CrossRefGoogle ScholarPubMed
Walker, SP, Rimm, EB, Ascherio, A, Kawachi, I, Stampfer, MJ, Willett, WC. Body size and fat distribution as predictors of stroke among US men. Am J Epidemiol 1996; 144:1143–50.CrossRefGoogle ScholarPubMed
Suk, SH, Sacco, RL, Boden-Albala, B, Cheun, JF, Pittman, JG, Elkind, MS, et al. Northern Manhattan Stroke Study. Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study. Stroke 2003; 34:1586–92.CrossRefGoogle ScholarPubMed
Curioni, C, Andre, C, Veras, R. Weight reduction for primary prevention of stroke in adults with overweight or obesity. Cochrane Database Syst Rev 2006; CD006062.
Neter, J, Stam, B, Kok, F, Grobbee, D, Geleijnse, J. Influence of weight reduction on blood pressure: A meta-analysis of randomized controlled trials. Hypertension 2003; 42:878–84.CrossRefGoogle ScholarPubMed
Shaw, K, Gennat, H, O'Rourke, P, Del Mar, C. Exercise for overweight or obesity. Cochrane Database Syst Rev 2006; CD003817.
Lee, C, Folsom, A, Blair, S. Physical activity and stroke risk: A meta-analysis. Stroke 2003; 34:2475–81.CrossRefGoogle ScholarPubMed
Deplanque, D, Masse, I, Lefebvre, C, Libersa, C, Leys, D, Bordet, R. Prior TIA, lipid-lowering drug use, and physical activity decrease ischemic stroke severity. Neurology 2006; 67:1403–10.CrossRefGoogle ScholarPubMed
Wannamethee, G, Shaper, AG. Physical activity and stroke in British middle aged men. BMJ 1992; 304:597–601.CrossRefGoogle ScholarPubMed
Thrift, AG, Donnan, GA, McNeil, JJ. Reduced risk of intracerebral hemorrhage with dynamic recreational exercise but not with heavy work activity. Stroke 2002; 33:559–64.CrossRefGoogle Scholar
Hu, FB, Stampfer, MJ, Colditz, GA, Ascherio, A, Rexrode, KM, Willett, WC, et al. Physical activity and risk of stroke in women. JAMA 2000; 283:2961–7.CrossRefGoogle ScholarPubMed
Hu, G, Sarti, C, Jousilahti, P, Silventoinen, K, Barengo, NC, Tuomilehto, J. Leisure time, occupational, and commuting physical activity and the risk of stroke. Stroke 2005; 36:1994–9.CrossRefGoogle ScholarPubMed
Lee, IM, Paffenbarger, RS. Physical activity and stroke incidence: the Harvard Alumni Health Study. Stroke 1998; 29:2049–54.CrossRefGoogle ScholarPubMed
Lee, IM, Hennekens, CH, Berger, K, Buring, JE, Manson, JE. Exercise and risk of stroke in male physicians. Stroke 1999; 30:1–6.CrossRefGoogle ScholarPubMed
Wendel-Vos, GC, Schuit, AJ, Feskens, EJ, Boshuizen, HC, Verschuren, WM, Saris, WH, et al. Physical activity and stroke: A meta-analysis of observational data. Int J Epidemiol 2004; 33:787–98.CrossRefGoogle ScholarPubMed
Cornelissen, VA, Fagard, RH. Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors. Hypertension 2005; 46:667–75.CrossRefGoogle ScholarPubMed
Shaw, K, Gennat, H, O'Rourke, P, Del Mar, C. Exercise for overweight or obesity. Cochrane Database Syst Rev 2006; CD003817.
Pomerleau, J, McKee, M, Lobstein, T, Knai, C. The burden of disease attributable to nutrition in Europe. Public Health Nutr 2003; 6:453–61.CrossRefGoogle Scholar
Ding, EL, Mozaffarian, D. Optimal dietary habits for the prevention of stroke. Semin Neurol 2006; 26:11–23.CrossRefGoogle ScholarPubMed
He, FJ, Nowson, CA, MacGregor, GA. Fruit and vegetable consumption and stroke: meta-analysis of cohort studies. Lancet 2006; 367:320–6.CrossRefGoogle ScholarPubMed
Joshipura, KJ, Ascherio, A, Manson, JE, Stampfer, MJ, Rimm, EB, Speizer, FE, et al. Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA 1999; 282:1233–9.CrossRefGoogle ScholarPubMed
Mellen, PB, Walsh, TF, Herrington, DM. Whole grain intake and cardiovascular disease: a meta-analysis. Nutr Metab Cardiovasc Dis 2008; 18:283–90.CrossRefGoogle ScholarPubMed
Sauvaget, C, Nagano, J, Allen, N, Kodama, K. Vegetable and fruit intake and stroke mortality in the Hiroshima/Nagasaki Life Span Study. Stroke 2003; 34:2355–60.CrossRefGoogle ScholarPubMed
Johnsen, SP, Overvad, K, Stripp, C, Tjønneland, A, Husted, SE, Sørensen, HT. Intake of fruit and vegetables and the risk of ischemic stroke in a cohort of Danish men and women. Am J Clin Nutr 2003; 78:57–64.CrossRefGoogle Scholar
He, K, Song, Y, Daviglus, ML, Liu, K, Horn, L, Dyer, AR, et al. Fish consumption and incidence of stroke: a meta-analysis of cohort studies. Stroke 2004; 35:1538–42.CrossRefGoogle ScholarPubMed
Mozaffarian, D, Rimm, EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006; 296:1885–99.CrossRefGoogle ScholarPubMed
Bouzan, C, Cohen, JT, Connor, WE, Kris-Etherton, PM, Gray, GM, König, A, et al. A quantitative analysis of fish consumption and stroke risk. Am J Prev Med 2005; 29:347–52.CrossRefGoogle ScholarPubMed
Nagata, C, Takatsuka, N, Shimizu, N, Shimizu, H. Sodium intake and risk of death from stroke in Japanese men and women. Stroke 2004; 35:1543–7.CrossRefGoogle ScholarPubMed
Stamler, J. The INTERSALT Study: background, methods, findings, and implications. Am J Clin Nutr 1997; 65:626S–42S.CrossRefGoogle ScholarPubMed
He, FJ, MacGregor, GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 2004; CD004937.
Sacks, FM, Svetkey, LP, Vollmer, WM, Appel, LJ, Bray, GA, Harsha, D, et al. DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344:3–10.CrossRefGoogle ScholarPubMed
Ascherio, A, Rimm, EB, Hernán, MA, Giovannucci, EL, Kawachi, I, Stampfer, MJ, et al. Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. Circulation 1998; 98:1198–204.CrossRefGoogle ScholarPubMed
Bazzano, , He, J, Ogden, LG, Loria, C, Vupputuri, S, Myers, L, et al. Dietary potassium intake and risk of stroke in US men and women: National Health and Nutrition Examination Survey I epidemiologic follow-up study. Stroke 2001; 32:1473–80.CrossRefGoogle ScholarPubMed
Morris, RC, Sebastian, A, Forman, A, Tanaka, M, Schmidlin, O. Normotensive salt sensitivity: effects of race and dietary potassium. Hypertension 1999; 33:18–23.CrossRefGoogle ScholarPubMed
Fung, TT, Chiuve, SE, McCullough, ML, Rexrode, KM, Logroscino, G, Hu, FB. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med 2008; 168:713–20.CrossRefGoogle ScholarPubMed
Lorgeril, M, Salen, P. The Mediterranean diet in secondary prevention of coronary heart disease. Clin Invest Med 2006; 29:154–8.Google ScholarPubMed
Howard, B, Horn, L, Hsia, J, Manson, J, Stefanick, M, Wassertheil-Smoller, S, et al. Low-fat dietary pattern and risk of cardiovascular disease: the women's health initiative randomized controlled dietary modification trial. JAMA 2006; 295:655–666.CrossRefGoogle ScholarPubMed
Nelson, HD, Humphrey, LL, Nygren, P, Teutsch, SM, Allan, JD. Postmenopausal hormone replacement therapy: scientific review. JAMA 2002; 288:872–81.CrossRefGoogle ScholarPubMed
Bath, PM, Gray, LJ. Association between hormone replacement therapy and subsequent stroke: a meta-analysis. BMJ 2005; 330:342.CrossRefGoogle ScholarPubMed
Gabriel-Sánchez, R, Carmona, L, Roque, M, Sánchez-Gómez, GL, Bonfill, X. Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev 2005: CD002229.
Farquhar, CM, Marjoribanks, J, Lethaby, A, Lamberts, Q, Suckling, JA. Cochrane, HT Study Group. Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev 2005; CD004143.
Riggs, BL, Hartmann, LC. Selective estrogen-receptor modulators – mechanisms of action and application to clinical practice. N Engl J Med 2003; 348:618–29.CrossRefGoogle ScholarPubMed
Barrett-Connor, E, Grady, D, Sashegyi, A, Anderson, PW, Cox, DA, Hoszowski, K, et al. MORE Investigators (Multiple Outcomes of Raloxifene Evaluation). Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial. JAMA 2002; 287:847–57.CrossRefGoogle ScholarPubMed
Barrett-Connor, E, Mosca, L, Collins, P, Geiger, MJ, Grady, D, Kornitzer, M, et al. Raloxifene Use for The Heart (RUTH) Trial Investigators. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med 2006; 355:125–37.CrossRefGoogle ScholarPubMed
Bushnell, CD, Goldstein, LB. Risk of ischemic stroke with tamoxifen treatment for breast cancer: a meta-analysis. Neurology 2004; 63:1230–3.CrossRefGoogle ScholarPubMed
Lawes, CM, Vander Hoorn, S, Rodgers, A. International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet 2008; 371:1513–8.CrossRefGoogle ScholarPubMed
Lewington, S, Clarke, R, Qizilbash, N, Peto, R, Collins, R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903–13.Google ScholarPubMed
Lawes, CM, Bennett, DA, Feigin, VL, Rodgers, A. Blood pressure and stroke: an overview of published reviews. Stroke 2004; 35:1024.CrossRefGoogle ScholarPubMed
Mancia, G, Backer, G, Dominiczak, A, Cifkova, R, Fagard, R, Germano, G, et al. Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28:1462–536.Google Scholar
Mancia, G. Optimal control of blood pressure in patients with diabetes reduces the incidence of macro- and microvascular events. J Hypertens Suppl 2007; 25 Suppl 1:S7–12.CrossRefGoogle ScholarPubMed
Neal, B, MacMahon, S, Chapman, N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet 2000; 356:1955–64.Google ScholarPubMed
Turnbull, F. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003; 362:1527–35.Google ScholarPubMed
Staessen, JA, Li, Y, Thijs, L, Wang, JG. Blood pressure reduction and cardiovascular prevention: an update including the 2003–2004 secondary prevention trials. Hypertens Res 2005; 28:385–407.CrossRefGoogle ScholarPubMed
Lindholm, LH, Carlberg, B, Samuelsson, O. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 2005; 366:1545–53.CrossRefGoogle ScholarPubMed
Staessen, J, Fagard, R, Thijs, L, Celis, H, Arabidze, G, Birkenhager, W, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The systolic hypertension in Europe (syst-eur) trial investigators. Lancet 1997; 350:757–64.CrossRefGoogle ScholarPubMed
,Blood Pressure Lowering Treatment Trialists' Collaboration, Turnbull, F, Neal, B, Ninomiya, T, Algert, C, Arima, H, Barzi, F, et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 2008; 336:1121–3.Google ScholarPubMed
Beckett, NS, Peters, R, Fletcher, AE, Staessen, JA, Liu, L, Dumitrascu, D, et al. HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358:1887–98.CrossRefGoogle ScholarPubMed
Turner, RC, Cull, CA, Frighi, V, Holman, RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999; 281:2005–12.CrossRefGoogle ScholarPubMed
,UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352:837–53.
Boden-Albala, B, Cammack, S, Chong, J, Wang, C, Wright, C, Rundek, T, et al. Diabetes, fasting glucose levels, and risk of ischemic stroke and vascular events: findings from the Northern Manhattan Study (NOMAS). Diabetes Care 2008; 31:1132–7.CrossRefGoogle Scholar
Gerstein, HC, Miller, ME, Byington, RP, Goff, DC, Bigger, JT, Buse, JB, et al. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358:2545–59.Google Scholar
Patel, A, MacMahon, S, Chalmers, J, Neal, B, Billot, L, Woodward, M, et al. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358:2560–72.Google Scholar
Kannel, WB, Wilson, PW, Zhang, TJ. The epidemiology of impaired glucose tolerance and hypertension. Am Heart J 1991; 121:1268–73.CrossRefGoogle ScholarPubMed
,UK Prospective Diabetes Study 27. Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex. Diabetes Care 1997; 20:1683–7.
Collins, R, Armitage, J, Parish, S, Sleigh, P, Peto, R. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003; 361:2005–16.Google Scholar
Sever, PS, Poulter, NR, Dahlof, B, Wedel, H, Collins, R, Beevers, G, et al. Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial–lipid-lowering arm (ASCOT-LLA). Diabetes Care 2005; 28:1151–7.CrossRefGoogle Scholar
,Prospective studies collaboration. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet 1995; 346:1647–53.
Lewington, S, Whitlock, G, Clarke, R, Sherliker, P, Emberson, J, Halsey, J, et al. Prospective Studies Collaboration. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007; 370:1829–39.Google ScholarPubMed
Shahar, E, Chambless, , Rosamond, WD, Boland, LL, Ballantyne, CM, McGovern, PG, et al. Atherosclerosis Risk in Communities Study. Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 2003; 34:623–31.CrossRefGoogle ScholarPubMed
Amarenco, P, Labreuche, J, Lavallee, P, Touboul, P. Statins in stroke prevention and carotid atherosclerosis: Systematic review and up-to-date meta-analysis. Stroke 2004; 35:2902–9.CrossRefGoogle ScholarPubMed
O'Regan, C, Wu, P, Arora, P, Perri, D, Mills, EJ. Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients. Am J Med 2008; 121:24–33.CrossRefGoogle ScholarPubMed
Fitzmaurice, E, Wendell, L, Snider, R, Schwab, K, Chanderraj, R, Kinnecom, C, et al. Effect of statins on intracerebral hemorrhage outcome and recurrence. Stroke 2008; 39:2151–4.CrossRefGoogle ScholarPubMed
Josan, K, Majumdar, SR, McAlister, FA. The efficacy and safety of intensive statin therapy: a meta-analysis of randomized trials. CMAJ 2008; 178:576–84.CrossRefGoogle ScholarPubMed
Goldstein, LB, Amarenco, P, Szarek, M, Callahan, A, Hennerici, M, Sillesen, H, et al. SPARCL Investigators. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology 2008; 70:2364–70.CrossRefGoogle ScholarPubMed
Corvol, JC, Bouzamondo, A, Sirol, M, Hulot, JS, Sanchez, P, Lechat, P. Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials. Arch Intern Med 2003; 163:669–76.CrossRefGoogle ScholarPubMed
Wolf, PA, Abbott, RD, Kannel, WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22:983–8.CrossRefGoogle ScholarPubMed
Go, AS, Hylek, EM, Phillips, KA, Chang, Y, Henault, , Selby, JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285:2370–5.CrossRefGoogle ScholarPubMed
Steger, C, Pratter, A, Martinek-Bregel, M, Avanzini, M, Valentin, A, Slany, J, et al. Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry. Eur Heart J 2004; 25:1734–40.CrossRefGoogle ScholarPubMed
Roquer, J, Rodríguez-Campello, A, Gomis, M, Ois, A, Martínez-Rodríguez, JE, Munteis, E, et al. Comparison of the impact of atrial fibrillation on the risk of early death after stroke in women versus men. J Neurol 2006; 253:1484–9.CrossRefGoogle ScholarPubMed
,Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology 2007; 69:546–54.
,Stroke Risk in Atrial Fibrillation Working Group. Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation. Stroke 2008; 39:1901–10.
Gross, CP, Vogel, EW, Dhond, AJ, Marple, CB, Edwards, RA, Hauch, O, et al. Factors influencing physicians' reported use of anticoagulation therapy in nonvalvular atrial fibrillation: a cross-sectional survey. Clin Ther 2003; 25:1750–64.CrossRefGoogle ScholarPubMed
Stafford, RS, Radley, DC. The underutilization of cardiac medications of proven benefit, 1990 to 2002. J Am Coll Cardiol 2003; 41:56–61.CrossRefGoogle ScholarPubMed
Hart, RG, Pearce, , Aguilar, MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146:857–67.CrossRefGoogle ScholarPubMed
Aguilar, MI, Hart, R, Pearce, . Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. Cochrane Database Syst Rev 2007; CD006186.
Go, AS, Hylek, EM, Chang, Y, Phillips, KA, Henault, , Capra, AM, et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?JAMA 2003; 290:2685–92.CrossRefGoogle ScholarPubMed
Fang, MC, Go, AS, Hylek, EM, Chang, Y, Henault, , Jensvold, NG, et al. Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study. J Am Geriatr Soc 2006; 54:1231–6.CrossRefGoogle ScholarPubMed
Rash, A, Downes, T, Portner, R, Yeo, W, Morgan, N, Channer, K. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO). Age Ageing 2007; 36:151–6.CrossRefGoogle Scholar
Mant, J, Hobbs, FD, Fletcher, K, Roalfe, A, Fitzmaurice, D, Lip, GY, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007; 370:493–503.CrossRefGoogle Scholar
Hart, RG, Pearce, , Rothbart, RM, McAnulty, JH, Asinger, RW, Halperin, JL. Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 2000; 35:183–7.CrossRefGoogle ScholarPubMed
Salem, DN, Stein, PD, Al-Ahmad, A, Bussey, HI, Horstkotte, D, Miller, N, et al. Antithrombotic therapy in valvular heart disease – native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126:457S–82S.CrossRefGoogle ScholarPubMed
Bonow, RO, Carabello, BA, Kanu, C, Leon, AC, Faxon, DP, Freed, MD, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006; 114:e84–231.

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×